News & Event
- Home
- News
- News & Event
Munmak Foreign Investment Zone in Wonju Signed Investment Agreement with Japanese Company
The company has developed lactic acid bacteria EF-2001, which is highly effective for intestinal regulations and immunity, and has a patent for their biological response modifiers (BRMs).
Lactic acid bacteria EF-2001 is effective for those with immune problems and can be widely applied from food to cosmetics.
Nihon Berumu Co. will sign a tenancy contract in the coming September and invest KRW 4 billion to complete the establishment of the plant in the early next year on 3,300 ㎡ land.
If the project goes as planned, Nihon Berumu Co. will be the first tenant in the Munmak Foreign Investment Zone.
Copyrights Yonhap News. All Rights Reserved. Source Text
Source: Yonhap News (July. 14, 2014)
** This article was translated from the Korean.
Date
2014.07.21
Views
487
According to Yonhap News,
(WONJU=Yon Hap News) The investment agreement ceremony on Munmak Foreign Investment Zone in Wonju was held on July 14 at Wonju City Hall with Gangwon Governor Choi Moon-Soon, Wonju Mayor Won Chang-Muk, President Iwasa Toshihiro of Nihon Berumu Co. and President Kang Nam-hoon of Korea Industrial Complex Corp.
The company has developed lactic acid bacteria EF-2001, which is highly effective for intestinal regulations and immunity, and has a patent for their biological response modifiers (BRMs).
Lactic acid bacteria EF-2001 is effective for those with immune problems and can be widely applied from food to cosmetics.
Nihon Berumu Co. will sign a tenancy contract in the coming September and invest KRW 4 billion to complete the establishment of the plant in the early next year on 3,300 ㎡ land.
If the project goes as planned, Nihon Berumu Co. will be the first tenant in the Munmak Foreign Investment Zone.
Copyrights Yonhap News. All Rights Reserved. Source Text
Source: Yonhap News (July. 14, 2014)
** This article was translated from the Korean.